CNS Lymphatics

The CNS contains lymphatic vessels in the meninges that connect and drain the CSF into the peripheral lymphatic system. Impaired functioning of the CNS lymphatic system can be dangerous with the accumulation of toxic substances such as amyloid protein that is part of Alzheimer’s disease pathogenesis. Here is the latest research on the CNS lymphatics.

June 4, 2020
Case Report
Open Access

Secondary glioblastoma metastasis outside the central nervous system in a young HIV-infected patient

Therapeutic Advances in Medical Oncology
Leonardo Fonseca RodriguesTania Cristina Leite de Sampaio E Spohr
June 17, 2020

Primary Pancreatic Lymphoma: Clinical Presentation, Diagnosis, Treatment and Outcome

European Journal of Haematology
D FacchinelliC Tecchio
May 20, 2020

Triage of Patients with Venous and Lymphatic Diseases during the COVID-19 pandemic- the Venous and Lymphatic Triage and Acuity Scale (VELTAS)

Journal of Vascular Surgery. Venous and Lymphatic Disorders
Kurosh ParsiCees H A Wittens
June 24, 2020

HIV and systemic lupus erythematosus: where immunodeficiency meets autoimmunity

Lupus
Brendan O'KellyLaura Durcan
April 26, 2020
Open Access

Pericardial relapse of multiple myeloma

BMJ Case Reports
Lee S JamisonMary Kwok
June 23, 2020

Non-Hodgkin's Lymphoma of the Anterior Maxilla Mimicking a Chronic Apical Abscess

Journal of Endodontics
Joseph A ShilkofskiNader K Salib
June 20, 2020
Review

New and Emerging Targeted Therapies for Vascular Malformations

American Journal of Clinical Dermatology
An Van DammeMiikka Vikkula
May 19, 2020
Review

Application of imaging in lymphedema surgical therapies

Gland Surgery
Xingyi Du, Chunjun Liu
May 20, 2020
Case Report
Open Access

Severe meningoencephalitis secondary to calvarial invasion of Lagenidium giganteum forma caninum in a dog

Open Veterinary Journal
Justin ShmalbergStuart A Walton
June 24, 2020

Thyroid cancer neck lymph nodes metastasis: Meta-analysis of US and CT diagnosis

European Journal of Radiology
Zhichao XingJingqiang Zhu
April 23, 2020
Review
Open Access

Brain Microvascular Pericytes in Vascular Cognitive Impairment and Dementia

Frontiers in Aging Neuroscience
Maiko T UemuraJohn Q Trojanowski
May 20, 2020
Open Access

A Single-Cell Transcriptional Roadmap of the Mouse and Human Lymph Node Lymphatic Vasculature

Frontiers in Cardiovascular Medicine
Menglan XiangEugene C Butcher
May 18, 2020

Targeting the PI3K/AKT/mTOR Signaling Pathway in Primary Central Nervous System Lymphoma: Current Status and Future Prospects

CNS & Neurological Disorders Drug Targets
Zhang Xiaowei, Liu Yuanbo
July 8, 2020
Open Access

Curcumin Containing PEGylated Solid Lipid Nanoparticles for Systemic Administration: A Preliminary Study

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Debora SantonocitoCarmelo Puglia
April 19, 2020

A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive Molecules

Journal of Molecular Biology
Zachary R CrookJames M Olson

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/cns-lymphatics/3dfb4bb5-3c08-46c3-80c1-60a2ef837ef9